Literature DB >> 34480601

High expression of Toll-like receptor 7 is a survival factor in pediatric medulloblastoma.

Lourdes Alvarez-Arellano1, Pilar Eguía-Aguilar2, Patricia Piña-Sánchez3, Nadia González-García4, Alam Palma-Guzman5, Mario Perezpeña-Diazconti6, Carmen Maldonado-Bernal7.   

Abstract

PURPOSE: Medulloblastoma is an embryonal brain tumor that predominantly occurs in childhood with a wide histological and molecular variability. Our aim was to investigate the expression of Toll-like receptors (TLRs), their association with the infiltration of immune cells and with the histological subgroups, and, also, with the overall survival of patients.
METHODS: Fifty-six paraffin-preserved biopsies from children with medulloblastoma of the classic, desmoplastic, and anaplastic subtypes were included. Microarrays of tissues were performed, and the infiltration of T and NK cells was quantified, as well as the expression of TLR7, TLR8, and TLR9. For all statistical analyses, significance was p < 0.05.
RESULTS: CD4 + and CD8 + T lymphocytes and NK cells were found infiltrating the tumor. The infiltration of NK and CD4 + cells was greater in the classic and desmoplastic subtypes than in anaplastic. We found an important expression of TLRs in all medulloblastomas, but TLR7 and TLR8 were considerably higher in classic and desmoplastic subtypes than in anaplastic. Importantly, we observed that TLR7 was a prognostic factor for survival.
CONCLUSIONS: Medulloblastomas present cellular infiltration and a differential expression of TLRs depending on the histological subtype. TLR7 is a prognostic factor of survival that is dependent on treatment and age.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Lymphocytes; Medulloblastoma; NK; TLR; Tumor

Mesh:

Substances:

Year:  2021        PMID: 34480601     DOI: 10.1007/s00381-021-05347-w

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  23 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 2.  Toll-like receptors and innate immunity.

Authors:  Himanshu Kumar; Taro Kawai; Shizuo Akira
Journal:  Biochem Biophys Res Commun       Date:  2009-08-15       Impact factor: 3.575

3.  Histopathologic grading of medulloblastomas: a Pediatric Oncology Group study.

Authors:  Charles G Eberhart; James L Kepner; Patricia T Goldthwaite; Larry E Kun; Patricia K Duffner; Henry S Friedman; Douglas R Strother; Peter C Burger
Journal:  Cancer       Date:  2002-01-15       Impact factor: 6.860

4.  Intertumoral Heterogeneity within Medulloblastoma Subgroups.

Authors:  Florence M G Cavalli; Marc Remke; Ladislav Rampasek; John Peacock; David J H Shih; Betty Luu; Livia Garzia; Jonathon Torchia; Carolina Nor; A Sorana Morrissy; Sameer Agnihotri; Yuan Yao Thompson; Claudia M Kuzan-Fischer; Hamza Farooq; Keren Isaev; Craig Daniels; Byung-Kyu Cho; Seung-Ki Kim; Kyu-Chang Wang; Ji Yeoun Lee; Wieslawa A Grajkowska; Marta Perek-Polnik; Alexandre Vasiljevic; Cecile Faure-Conter; Anne Jouvet; Caterina Giannini; Amulya A Nageswara Rao; Kay Ka Wai Li; Ho-Keung Ng; Charles G Eberhart; Ian F Pollack; Ronald L Hamilton; G Yancey Gillespie; James M Olson; Sarah Leary; William A Weiss; Boleslaw Lach; Lola B Chambless; Reid C Thompson; Michael K Cooper; Rajeev Vibhakar; Peter Hauser; Marie-Lise C van Veelen; Johan M Kros; Pim J French; Young Shin Ra; Toshihiro Kumabe; Enrique López-Aguilar; Karel Zitterbart; Jaroslav Sterba; Gaetano Finocchiaro; Maura Massimino; Erwin G Van Meir; Satoru Osuka; Tomoko Shofuda; Almos Klekner; Massimo Zollo; Jeffrey R Leonard; Joshua B Rubin; Nada Jabado; Steffen Albrecht; Jaume Mora; Timothy E Van Meter; Shin Jung; Andrew S Moore; Andrew R Hallahan; Jennifer A Chan; Daniela P C Tirapelli; Carlos G Carlotti; Maryam Fouladi; José Pimentel; Claudia C Faria; Ali G Saad; Luca Massimi; Linda M Liau; Helen Wheeler; Hideo Nakamura; Samer K Elbabaa; Mario Perezpeña-Diazconti; Fernando Chico Ponce de León; Shenandoah Robinson; Michal Zapotocky; Alvaro Lassaletta; Annie Huang; Cynthia E Hawkins; Uri Tabori; Eric Bouffet; Ute Bartels; Peter B Dirks; James T Rutka; Gary D Bader; Jüri Reimand; Anna Goldenberg; Vijay Ramaswamy; Michael D Taylor
Journal:  Cancer Cell       Date:  2017-06-12       Impact factor: 31.743

Review 5.  Toll-like receptor signaling in cell proliferation and survival.

Authors:  Xinyan Li; Song Jiang; Richard I Tapping
Journal:  Cytokine       Date:  2009-09-22       Impact factor: 3.861

6.  Incidence of childhood cancer among Mexican children registered under a public medical insurance program.

Authors:  Roberto Rivera-Luna; Cecilia Correa-González; Eduardo Altamirano-Alvarez; Fernando Sánchez-Zubieta; Rocio Cárdenas-Cardós; Gabriela Escamilla-Asian; Alberto Olaya-Vargas; Aurora Bautista-Marquez; Manuel Aguilar-Romo
Journal:  Int J Cancer       Date:  2012-08-28       Impact factor: 7.396

Review 7.  Immuno-oncology: understanding the function and dysfunction of the immune system in cancer.

Authors:  O J Finn
Journal:  Ann Oncol       Date:  2012-09       Impact factor: 32.976

8.  Novel mutations target distinct subgroups of medulloblastoma.

Authors:  Giles Robinson; Matthew Parker; Tanya A Kranenburg; Charles Lu; Xiang Chen; Li Ding; Timothy N Phoenix; Erin Hedlund; Lei Wei; Xiaoyan Zhu; Nader Chalhoub; Suzanne J Baker; Robert Huether; Richard Kriwacki; Natasha Curley; Radhika Thiruvenkatam; Jianmin Wang; Gang Wu; Michael Rusch; Xin Hong; Jared Becksfort; Pankaj Gupta; Jing Ma; John Easton; Bhavin Vadodaria; Arzu Onar-Thomas; Tong Lin; Shaoyi Li; Stanley Pounds; Steven Paugh; David Zhao; Daisuke Kawauchi; Martine F Roussel; David Finkelstein; David W Ellison; Ching C Lau; Eric Bouffet; Tim Hassall; Sridharan Gururangan; Richard Cohn; Robert S Fulton; Lucinda L Fulton; David J Dooling; Kerri Ochoa; Amar Gajjar; Elaine R Mardis; Richard K Wilson; James R Downing; Jinghui Zhang; Richard J Gilbertson
Journal:  Nature       Date:  2012-08-02       Impact factor: 49.962

9.  Subtypes of medulloblastoma have distinct developmental origins.

Authors:  Paul Gibson; Yiai Tong; Giles Robinson; Margaret C Thompson; D Spencer Currle; Christopher Eden; Tanya A Kranenburg; Twala Hogg; Helen Poppleton; Julie Martin; David Finkelstein; Stanley Pounds; Aaron Weiss; Zoltan Patay; Matthew Scoggins; Robert Ogg; Yanxin Pei; Zeng-Jie Yang; Sonja Brun; Youngsoo Lee; Frederique Zindy; Janet C Lindsey; Makoto M Taketo; Frederick A Boop; Robert A Sanford; Amar Gajjar; Steven C Clifford; Martine F Roussel; Peter J McKinnon; David H Gutmann; David W Ellison; Robert Wechsler-Reya; Richard J Gilbertson
Journal:  Nature       Date:  2010-12-08       Impact factor: 49.962

10.  Aberrant expression of interleukin-1β and inflammasome activation in human malignant gliomas.

Authors:  Leonid Tarassishin; Diana Casper; Sunhee C Lee
Journal:  PLoS One       Date:  2014-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.